NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM3585284 Query DataSets for GSM3585284
Status Public on Jan 15, 2022
Title 24h_5mgYFSJ_75uMgefitinib [Y5_G75_1]
Sample type SRA
 
Source name H1975_24h_5mgYFSJ_75uMgefitinib
Organism Homo sapiens
Characteristics cell line: H1975
tumor type: non-small cell lung cancer
treatment: 24h_5mgYFSJ_75uMgefitinib
Treatment protocol Drug treatments were designed as follows: CKI in 2 doses (1.0 mg/mL and 2.0 mg/mL), YFSJ in 2 doses (2.5 mg/ml and 5 mg/ml) and gefitinib in two doses (50 uM and 75 uM); Two doses of CKI combined with two doses of gefitinib; Two doses of YFSJ combined with two doses of gefitinib.
Growth protocol Human EGFR mutated NSCLC cell line H1975 was purchased from ATCC (HTB-22™, VA, USA) and were cultured in RPMI-1640 medium (Thermo Fisher Scientifc, MA, USA) supplemented with 10% fetal bovine serum (Thermo Fisher Scientifc, MA, USA) at 37°C with 5% CO2.
Extracted molecule total RNA
Extraction protocol Total RNA was isolated using PureLink™ RNA Mini Kit (Thermo Fisher Scientific) according to the manufacturer’s protocol.
RNA libraries were prepared using NEBNext® UltraTM RNA Library Prep Kit for Illumina® (NEB, Massachusetts, USA) according to the manufacturer's protocol.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model HiSeq X Ten
 
Description unstranded paired-end RNA-seq
Data processing Illumina Casava1.7 software used for basecalling.
Low quality and adaptor sequences in raw reads were trimmed using Trim_galore (v0.4.2, Babraham Bioinformatics) with the following parameters: --stringency 6 --paired. Then cleaned reads were aligned to the reference genome (hg19, UCSC) using STAR_2.5.3a with the following parameters: --outFilterMismatchNmax 10 --outFilterMismatchNoverLmax 0.05 --seedSearchStartLmax 30 –quantMode GeneCounts
Differential expression analysis was performed with edgeR and DE genes were selected with a False Discovery Rate (FDR) < 0.05.
Genome_build: hg19, UCSC
Supplementary_files_format_and_content: Tab delimited matrix showing raw counts of refGenes
 
Submission date Jan 31, 2019
Last update date Jan 15, 2022
Contact name Lizhu Lin
E-mail(s) lizhulin05@gmail.com
Organization name Guangzhou University of Chinese Medicine
Street address 12 Jichang Street, Baiyun District
City Guangzhou
ZIP/Postal code 510000
Country China
 
Platform ID GPL20795
Series (1)
GSE125933 Compound kushen injection and YFSJ reduce gefitinib resistance in gefitinib resistant lung cancer cell lines
Relations
BioSample SAMN10850800
SRA SRX5314333

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap